BPIQ Blog

Nov 9, 20224 min read

Are Mid-Term Results Good for Biotech Investors?

SUMMARY The drug-price reform focus of Congress affects biopharma stock prices The likelihood that Republicans will control at least the...

Jul 11, 20225 min read

Biotech stocks are down ~40% since Jan 1, 2021, underperforming the broader markets The democratic white house and Congress since January...

Our platform helps you uncover your next biotech investment opportunity